Daniel Peter Andersson

Daniel Peter Andersson

Auto-generated profile, based on publicly available information

Daniel Peter Andersson

Department of Medicine-H7 at Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2010 in Diabetologia
Verified
Journal Article
Open access
PDF file
JHJ. Hoffstedt
J. Hoffstedt
EAE. Arner
E. Arner
HWH. Wahrenberg
H. Wahrenberg
DAD. P. Andersson
D. P. Andersson
VQV. Qvisth
V. Qvisth
PAP. Arner
P. Arner
The aim of this study was to determine whether the mean size of fat cells in either visceral or subcutaneous adipose tissue has an impact on the metabolic and inflammatory profiles in morbid obesity.

25 November 2015 in Diabetologia
Verified
Journal Article
Open access
PDF file
JAJuan R. Acosta
Juan R. Acosta
IDIyadh Douagi
Iyadh Douagi
DADaniel P. Andersson
Daniel P. Andersson
JBJesper Bäckdahl
Jesper Bäckdahl
MRMikael Rydén
Mikael Rydén
JLJurga Laurencikiene
Jurga Laurencikiene
Aims/hypothesis We aimed to elucidate the impact of fat cell size and inflammatory status of adipose tissue on the development of type 2 diabetes in non-obese individuals. Methods We characterised subcutaneous abdominal adipose tissue by examining stromal cell populations by 13 colour flow cytometry, measuring expression of adipogenesis genes in the progenitor cell fraction and determining lipolysis and adipose secretion of inflammatory proteins in 14 non-obese men with type 2 diabetes and 13 healthy controls matched for age, sex, body weight and total fat mass. Results Individuals with diabetes had larger fat cells than the healthy controls but stromal cell population frequencies, adipose lipolysis and secretion of inflammatory proteins did not differ between the two groups. However, in the entire cohort fat cell size correlated positively with the ratio of M1/M2 macrophages, TNF-α secretion, lipolysis and insulin resistance. Expression of genes encoding regulators of adipogenesis and adipose morphology (BMP4, CEBPα [also known as CEBPA], PPARγ [also known as PPARG] and EBF1) correlated negatively with fat cell size. Conclusions/interpretation We show that a major phenotype of white adipose tissue in non-obese individuals with type 2 diabetes is adipocyte hypertrophy, which may be mediated by an impaired adipogenic capacity in progenitor cells. Consequently, this could have an impact on adipose tissue inflammation, release of fatty acids, ectopic fat deposition and insulin sensitivity.

1 July 2018 in Cell Metabolism
Verified
Journal Article
Closed access
PAPeter Arner
Peter Arner
DADaniel P. Andersson
Daniel P. Andersson
JBJesper Bäckdahl
Jesper Bäckdahl
IDIngrid Dahlman
Ingrid Dahlman
MRMikael Rydén
Mikael Rydén

9 September 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
PAP. Arner
P. Arner
SBS. Bernard
S. Bernard
LAL. Appelsved
L. Appelsved
KFK.-Y. Fu
K.-Y. Fu
DAD. P. Andersson
D. P. Andersson
KSK. L. Spalding
K. L. Spalding

1 October 2014 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
MRMikael Rydén
Mikael Rydén
DADaniel P. Andersson
Daniel P. Andersson
IBIngrid B. Bergström
Ingrid B. Bergström
PAPeter Arner
Peter Arner
Objective: White adipose tissue can expand by increasing the size and/or number of fat cells. Although increased sc and visceral fat cell size associates with an adverse metabolic profile, the relationship with fat cell number in either depot is unknown. We hypothesized that adipocyte number and size displayed different relationships with clinically relevant metabolic variables. Methods: This was a cross-sectional study of 204 patients scheduled for gastric bypass surgery. Fat cell size and number were determined in visceral and abdominal sc adipose tissue and related to insulin sensitivity (by hyperinsulinemic euglycemic clamp), fasting plasma levels of insulin, triglycerides and high-density lipoprotein (HDL) cholesterol. Results: Visceral and sc fat cell volumes were positively correlated with insulin and triglyceride levels and negatively with insulin sensitivity and HDL-cholesterol (P = .0020 or better). In contrast, although visceral fat cell number did not associate with any metabolic parameter, sc adipocyte number displayed a positive association with insulin sensitivity and HDL-cholesterol and a negative relationship with insulin and triglyceride levels (P = .0014 or better). All results were independent of body fat mass. Conclusions: Variations in fat cell size and number correlate differently with metabolic parameters in obesity. Increased fat cell size in visceral and sc depots associates with a pernicious metabolic profile, whereas increased sc, but not visceral, fat cell number correlates with a more beneficial phenotype. Whether determination of sc fat cell number, in addition to adipocyte size, may have a predictive value for the risk of type 2 diabetes needs to be demonstrated in prospective or mechanistic studies.

18 March 2015 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
IDIngrid Dahlman
Ingrid Dahlman
ISIndranil Sinha
Indranil Sinha
HGH Gao
H Gao
DBD Brodin
D Brodin
ATAnders Thorell
Anders Thorell
PAP Arner
P Arner